BDBM236617 US9388136, Table 1, Compound 3:tert-Butyl N-[2-(4-{6- amino-5- [(2,4-difluoro- phenyl) carbonyl]-2- oxopyridin- 1(2H)-yl} phenyl)ethyl]- L-leucinate

SMILES CC(C)C[C@H](NCCc1ccc(cc1)-n1c(N)c(ccc1=O)C(=O)c1ccc(F)cc1F)C(=O)OC(C)(C)C

InChI Key InChIKey=UOKYZXXITPRNLY-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 236617   

TargetMitogen-activated protein kinase 14(Human)
Chroma Therapeutics

US Patent
LigandPNGBDBM236617(US9388136, Table 1, Compound 3:tert-Butyl N-[2-(4-...)
Affinity DataIC50: 58nMpH: 7.5 T: 2°CAssay Description:The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2017
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Chroma Therapeutics

US Patent
LigandPNGBDBM236617(US9388136, Table 1, Compound 3:tert-Butyl N-[2-(4-...)
Affinity DataIC50: 330nMpH: 7.5 T: 2°CAssay Description:The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2017
Entry Details
US Patent